Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop

Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells

(2017) Jung-Hyun Kim et al.   Stem Cells Translational Medicine

Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications

(2017) Peter W. Andrews et al.   Stem Cell Reports

Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015

(2016) David J Williams et al.   Regenerative Medicine

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)

(2015) PW Andrews et al.   Regenerative Medicine

Quantification of biological variation in blood-based therapy - a summary of a meta-analysis to inform manufacturing in the clinic

(2015) J. A. Thurman-Newell et al.   VOX SANGUINIS

Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies

(2015) James A. Heslop et al.   Stem Cells Translational Medicine

Differentiated human stem cells resemble fetal, not adult, β cells

(2014) Sinisa Hrvatin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Toward the Development of a Global Induced Pluripotent Stem Cell Library

(2013) Marc Turner et al.   Cell Stem Cell

Lessons from the heart: Mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes

(2013) Nikki H.L. van den Heuvel et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Stability of human mesenchymal stem cells duringin vitroculture: considerations for cell therapy

(2012) R. Binato et al.   CELL PROLIFERATION

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage

(2011)   NATURE BIOTECHNOLOGY

Differentiation of Embryonic Stem Cells to Clinically Relevant Populations: Lessons from Embryonic Development

(2008) Charles E. Murry et al.   CELL